All samples with a pathological assessment of well-differentiated neuroendocrine tumors of the small intestine or metastasis of the small intestine and a signed informed consent were included as part of the study. Those samples with sufficient native genomic DNA were used for SNP arrays, whole-exome or whole-genome sequencing. Samples were removed from analysis when there was a poor concordance between tumor and normal SNPs. Samples that did not meet whole-exome capture and/or sequencing requirements were also removed from the analysis.
Item
All samples with a pathological assessment of well-differentiated neuroendocrine tumors of the small intestine or metastasis of the small intestine and a signed informed consent were included as part of the study. Those samples with sufficient native genomic DNA were used for SNP arrays, whole-exome or whole-genome sequencing. Samples were removed from analysis when there was a poor concordance between tumor and normal SNPs. Samples that did not meet whole-exome capture and/or sequencing requirements were also removed from the analysis.
boolean
C1512693 (UMLS CUI [1,1])
C0030664 (UMLS CUI [1,2])
C0205615 (UMLS CUI [1,3])
C0206754 (UMLS CUI [1,4])
C0345832 (UMLS CUI [1,5])
C0563486 (UMLS CUI [1,6])
C0021430 (UMLS CUI [1,7])
C3272453 (UMLS CUI [1,8])
C3897601 (UMLS CUI [1,9])
C3640076 (UMLS CUI [1,10])
C3640077 (UMLS CUI [1,11])
C0680251 (UMLS CUI [2,1])
C0752046 (UMLS CUI [2,2])
C5237802 (UMLS CUI [2,3])
C1705241 (UMLS CUI [2,4])
C0680251 (UMLS CUI [3,1])
C4319199 (UMLS CUI [3,2])
C5236167 (UMLS CUI [3,3])